In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats.
BACKGROUND
Environmental estrogens are exogenous estrogen-mimicking compounds that can interfere with endogenous endocrine systems. Several of these endocrine disruptors have been shown to alter normal development and influence tumorigenesis in experimental models. N-butyl benzyl phthalate (BBP), a widely used plasticizer, is a well-known endocrine disruptor. The aim of this study was to elucidate the effect of prenatal exposure to BBP on the morphology, proliferative index, and genomic signature of the rat mammary gland at different ages.


METHODS
In utero exposure was performed by gavage of pregnant Sprague Dawley CD rats with 120mg or 500mg BBP/kg/day from day 10 post-conception to delivery. Female litters were euthanized at 21, 35, 50 and 100 days. The morphology and proliferative index of the mammary gland were studied from whole mount preparations and BrdU incorporation, respectively. Gene expression profile was assessed by microarrays. Several genes found differentially expressed and related to different functional categories were further validated by real time RT-PCR.


RESULTS
Prenatal exposure of BBP induced delayed vaginal opening and changes in the post-natal mammary gland long after the end of the treatment, mainly by 35 days of age. Exposure to the high dose resulted in modifications in architecture and proliferative index of the mammary gland, mostly affecting the undifferentiated terminal end buds. Moreover, the expression profiles of this gland in the exposed rats were modified in a dose-dependent fashion. Analysis of functional categories showed that modified genes were related to immune function, cell signaling, proliferation and differentiation, or metabolism.


CONCLUSIONS
Our data suggest that in utero exposure to BBP induced a delayed pubertal onset and modified morphology of the mammary gland. These alterations were accompanied by modifications in gene expression previously associated with an increased susceptibility to carcinogenesis.
Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Raquel.Moral@uab.es
Raquel
R
Moral
Julia
J
Santucci-Pereira
Richard
R
Wang
Irma H
IH
Russo
Coral A
CA
Lamartiniere
Jose
J
Russo
D000818:Animals; D005260:Female; D005333:Fetus; D020869:Gene Expression Profiling; D008321:Mammary Glands, Animal / Q000187:drug effects* / Q000473:pathology; D010795:Phthalic Acids / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013723:Teratogens / Q000032:analysis / Q000378:metabolism / Q000633:toxicity*
D010795:Phthalic Acids; D013723:Teratogens; C027561:butylbenzyl phthalate
Environ Health Perspect. 2009 Jun;117(6):910-5
19590682
Environ Health Perspect. 2003 Feb;111(2):139-45
12573895
J Toxicol Environ Health B Crit Rev. 2009 Apr;12(4):225-49
20183522
J Nutr. 2001 Jan;131(1):154S-157S
11208953
Mol Cell Proteomics. 2005 Apr;4(4):492-522
15695426
Environ Health Perspect. 2010 Nov;118(11):1614-9
20675265
Biol Pharm Bull. 2004 Jul;27(7):1136-9
15256756
Breast Cancer Res Treat. 2011 Aug;128(3):667-77
20821348
Environ Health Perspect. 2003 Apr;111(4):389-94
12676588
Neuroendocrinology. 2001 Aug;74(2):77-81
11474214
J Toxicol Sci. 2005 Dec;30 Spec No.:39-58
16641542
Carcinogenesis. 1997 Aug;18(8):1669-73
9276647
Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):102-18
9339487
Biol Reprod. 2005 Jul;73(1):180-92
15728792
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8064-8
7644538
Reprod Toxicol. 2000 Nov-Dec;14(6):513-32
11099877
J Mammary Gland Biol Neoplasia. 2010 Sep;15(3):275-7
20824491
Reprod Toxicol. 2004 Mar-Apr;18(2):241-64
15019722
BMC Genomics. 2007 Dec 06;8:453
18062813
J Endocrinol. 2008 Jan;196(1):101-12
18180321
J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):49-61
10819504
NTP CERHR MON. 2003 Mar;(5):i-III90
15995737
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18481-6
20937869
Am J Pathol. 1980 Aug;100(2):497-512
6773421
Proc Nutr Soc. 2008 Aug;67(3):253-6
18452640
Environ Health Perspect. 2004 Mar;112(3):331-8
14998749
Environ Health Perspect. 2004 Oct;112(14):1393-7
15471731
J Natl Cancer Inst. 1978 Dec;61(6):1451-9
102857
Rev Endocr Metab Disord. 2007 Jun;8(2):161-71
17657605
Lab Invest. 1990 Mar;62(3):244-78
2107367
Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H3201-9
17873008
Int J Hyg Environ Health. 2009 Sep;212(5):492-8
19423389
J Proteomics. 2010 Apr 18;73(6):1241-53
20219716
Toxicol Lett. 2004 Feb 2;146(3):207-15
14687758
Int J Androl. 2006 Feb;29(1):140-7; discussion 181-5
16102138
Environ Health Perspect. 2005 Aug;113(8):1056-61
16079079
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Mol Cell Endocrinol. 2009 May 25;304(1-2):43-8
19433246
BJOG. 2006 May;113(5):515-20
16637895